If you had bought Sasol on 1 January 2026, the decision would have sat between two very different narratives about coal-heavy assets and higher margin specialty chemicals. Investors who held Sasol from the start of the year are up 132.0%, including dividends. That outcome invites a harder question. At the time, were early buyers focusing more on surfactant commercialization and margin recovery, or on the risk of stricter climate rules and potential stranded projects?
Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.
The easy part of this move is behind Sasol. Zero in on 201 high quality undervalued stocks for companies trading below our estimates.
The shares cost ZAR106 at the start of the period, and anyone looking at Sasol had to decide whether specialty chemicals and higher margins could outweigh coal risk.
The bull Narrative set Fair Value at ZAR134, based on revenue growth of 4.0% a year and profit margins rising to 8.1%. The share was assumed to trade on a future P/E of 7.1x in three years.
The bear case pointed to a Fair Value of ZAR70, stressing tightening climate regulation, stranded coal-heavy assets, and rising compliance costs as key threats.
Sasol bringing its ISOSIV paraffin unit in Italy back into beneficial operation and lifting force majeure on key detergent feedstocks supported the bull case that specialty chemicals could help sustain margins. The bear view was not cleared away. H2 2026 results showed revenue at ZAR149,731m and net income at ZAR11,908m, with net margin at 8.0%, so climate and asset risk still sit unresolved. The evidence pointed in both directions.
The episode turned on one assumption: could Sasol translate chemicals availability into higher profitability? When you look at another stock built on a similar story, check whether reported net margin is moving toward the level that earlier forecasts used in their Fair Value calculations.
Sasol now trades at ZAR243, which leaves holders from the start of the year with a gain of 132.0% from the start of the year. The bearish analyst Narrative on Simply Wall St sees its Fair Value below that price, framing today's level as already baking in a demanding execution story.
The Narrative highlights coal exposure, balance sheet goals and project delivery as the pressure points behind that view. A buyer at ZAR243 is effectively assuming decarbonisation plans, chemicals repositioning and debt reduction all land cleanly. How does that square with the execution, regulatory and impairment risks the Narrative sets out?
"The main requirement is that Sasol converts its cost cutting, production reliability gains at Secunda and portfolio reset in International Chemicals into durable free cash flow that brings net debt below the stated dividend threshold, while managing gas project and regulatory risks."
That disagreement has a full argument behind it. → Uncover the lower Fair Value this Narrative argues for
The story behind this run has already been told. The next one could be taking shape somewhere else. Where could you start looking before it becomes the headline?
Three companies from the same screener. Open the full list of 199 financially solid companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com